Clinical Drug Insights
Parkinson's Drugs in India: Classes & Clinical Reference
A clinical overview of Parkinson india drug classes — levodopa-carbidopa, dopamine agonists, MAO-B and COMT inhibitors — and India's rising disease burden.
· 6 min read
The Medyzen blog
Everything about running a profitable hospital pharmacy.
Practical, India-specific guides on setup, licensing, costs, operations, and revenue — written for hospital owners and administrators.
Clinical Drug Insights
Parkinson Drug Cost in India: NPPA Ceiling Rates
Parkinson drug cost in India explained through NPPA ceiling pricing on levodopa-carbidopa formulations, why prices vary by strength, and long-term cost drivers.
· 5 min readClinical Drug Insights
Painkiller Side Effects: GI and Cardiovascular Risk
Painkiller side effects from NSAIDs explained: gastrointestinal bleeding rates, cardiovascular risk timelines, and how risk stratification should guide prescribing.
· 5 min readClinical Drug Insights
Painkiller Side Effects: A Prescriber's Guide for India
Real Indian data on NSAID painkiller side effects, GI/renal/cardiac risk, interactions, and what it means for hospital pharmacy stocking and counselling.
· 6 min readClinical Drug Insights
Painkiller Drug Interactions: What Actually Raises Risk
Painkiller side effects and drug interactions that matter clinically: NSAID bleeding risk, triple whammy AKI, opioid-benzodiazepine depression, and more.
· 9 min readClinical Drug Insights
Osteoarthritis Injections: Real Side Effects, by Type
The documented side effects of corticosteroid, hyaluronic acid and PRP injections for knee osteoarthritis, sourced from peer-reviewed evidence.
· 6 min readClinical Drug Insights
Osteoarthritis Injections: Types Used in India
A clinical breakdown of osteoarthritis injection types available in India: corticosteroids, hyaluronic acid, and PRP, sourced from systematic reviews.
· 6 min readClinical Drug Insights
Osteoarthritis Injection Availability in Hospital Pharmacies
Why osteoarthritis injections like hyaluronic acid and PRP are stocked inconsistently in Indian hospital pharmacies, and what drives the gap.
· 6 min readClinical Drug Insights
Osteoarthritis Injections in India: A Clinical Reference
Intra-articular injections for knee osteoarthritis in India: corticosteroid, hyaluronic acid and PRP evidence, ICMR treatment workflow, and real risks.
· 6 min readClinical Drug Insights
Osteoarthritis Injection Drug Interactions to Know
What prescribers should know about intra-articular corticosteroid and hyaluronic acid injections interacting with anticoagulants and diabetes medication.
· 5 min readClinical Drug Insights
Osteoarthritis Injection Cost in India: What Drives It
What drives osteoarthritis injection cost in India across corticosteroid, hyaluronic acid and PRP options, and what government schemes actually cover.
· 6 min read
Clinical Drug Insights
New Diabetes Drugs in India: SGLT2, GLP-1 & Tirzepatide
A clinical reference on new diabetes drug india options — SGLT2 inhibitors, GLP-1 agonists and tirzepatide — against India's 101-million-patient burden.
· 6 min readClinical Drug Insights
New Cancer Drugs in India: Approvals, Access & Cost
How new cancer drugs, including India's first CAR-T therapy, reach the market through CDSCO, and how NPPA's trade margin cap changed oncology pricing.
· 6 min readClinical Drug Insights
Migraine Natural & Non-Drug Adjuncts: The Evidence
What the evidence actually supports for riboflavin, magnesium and CoQ10 as migraine prophylaxis adjuncts in India, and where they fit alongside pharmacological therapy.
· 5 min readClinical Drug Insights
Migraine Treatment Names & Drug Classes Stocked in India
Migraine names by drug class used in Indian practice — NSAIDs, triptans, CGRP therapy and prophylactic agents — and what a hospital pharmacy actually stocks.
· 6 min readClinical Drug Insights
Migraine Treatment and Insurance Coverage in India
What Indian health insurance and PMJAY actually cover for migraine care, why CGRP therapies sit outside most policies, and what that means for a hospital.
· 5 min readClinical Drug Insights
Migraine Treatment Availability in Hospital Pharmacies
Why migraine-specific drugs are inconsistently stocked in Indian hospital pharmacies, what NLEM covers, and the real prescribing pattern gap.
· 6 min read
Clinical Drug Insights
Migraine Treatment in India: A Clinical Overview
A clinical reference on migraine treatment in India: drug classes, evidence tiers, real prescribing gaps, and what determines hospital pharmacy availability.
· 7 min readClinical Drug Insights
Migraine Treatment Drug Interactions to Know
Serotonin syndrome risk between triptans and SSRIs/SNRIs/MAOIs, and other migraine treatment drug interactions, sourced from PubMed and FDA case review.
· 6 min readClinical Drug Insights
Migraine Treatment Cost in India: A Clinical Cost Breakdown
What migraine care actually costs in India across acute drugs, prophylaxis, diagnostics and specialist visits, sourced from ICMR-linked studies and NPPA pricing.
· 6 min read
Models
Managed Hospital Pharmacy Services in India: How They Work
What a managed hospital pharmacy actually does, the three operating models in use across India, and how to tell if outsourcing beats running it yourself.
· 7 min readClinical Drug Insights
Levothyroxine Availability in India: What Affects Supply
Why levothyroxine's price-controlled, multi-manufacturer status shapes its availability in India, and why brand consistency matters more than for most drugs.
· 5 min readClinical Drug Insights
Knee Replacement Implant Names & Brands Available in India
CDSCO-registered knee replacement implant brands and systems sold in India, how NPPA caps their price, and what a hospital pharmacy needs to know.
· 6 min readClinical Drug Insights
Knee Replacement Insurance: Coverage, Waits, Rates
Knee replacement insurance coverage in India explained: IRDAI waiting period rules, CGHS package rates, PMJAY pricing, and what most policies exclude.
· 6 min read